Get the Stockscreener App
1.48
17.46%
0.22
Pre-market:
1.42
-0.06
-4.05%
Oncology Institute Inc stock is traded at $1.48, with a volume of 1.88M.
It is up +17.46% in the last 24 hours and up +73.69% over the past month.
See More
Previous Close:
$1.26
Open:
$1.26
24h Volume:
1.88M
Relative Volume:
2.35
Market Cap:
$110.58M
Revenue:
$361.07M
Net Income/Loss:
$-71.54M
P/E Ratio:
-1.8734
EPS:
-0.79
Net Cash Flow:
$-47.97M
1W Performance:
+22.31%
1M Performance:
+73.69%
6M Performance:
+363.66%
1Y Performance:
-3.90%
1-Day Range:
$1.241
$1.59
1-Week Range:
$0.97
$1.59
52-Week Range:
$0.1253
$1.63
Oncology Institute Inc Stock (TOI) Company Profile
Name
Oncology Institute Inc
Sector
Industry
Phone
562-735-3226
Address
18000 STUDEBAKER RD, CERRITOS
Compare TOI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TOI
Oncology Institute Inc
|
1.48 | 110.58M | 361.07M | -71.54M | -47.97M | -0.79 |
|
HCA
Hca Healthcare Inc
|
347.03 | 85.12B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.73 | 14.52B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
137.18 | 13.40B | 20.97B | 3.13B | 2.39B | 31.21 |
|
DVA
Davita Inc
|
154.29 | 13.32B | 12.67B | 827.68M | 1.42B | 9.27 |
|
UHS
Universal Health Services Inc
|
188.78 | 12.21B | 15.42B | 1.03B | 956.84M | 15.02 |
Oncology Institute Inc Stock (TOI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-24 | Resumed | Jefferies | Buy |
| Sep-14-22 | Initiated | Guggenheim | Buy |
| Aug-15-22 | Initiated | Jefferies | Buy |
Oncology Institute Inc Stock (TOI) Latest News
Virtu Financial LLC Takes $41,000 Position in The Oncology Institute, Inc. (NASDAQ:TOI) - Defense World
The Oncology Institute, Inc. (TOI): Among Stocks Insiders Were Buying In Q1 2025 - Yahoo Finance
TOI Launches Florida Oncology Network, a Fully Delegated - GlobeNewswire
The Oncology Institute announces launch of the Florida Oncology Network - TipRanks
Healthcare Expansion: TOI Unveils Florida Cancer Network, Secures 80K Patient Contracts - Stock Titan
The oncology institute targets profitability and $460M-$480M revenue in 2025 - MSN
Oncology institute CEO acquires $23,584 in stock By Investing.com - Investing.com Australia
Oncology institute’s chief medical officer buys $9,433 in stock By Investing.com - Investing.com Canada
Oncology Institute Executives Make Bold Moves with Major Stock Purchases - TipRanks
Oncology institute director Karen Johnson acquires $37,734 in shares By Investing.com - Investing.com South Africa
Oncology institute’s COO Jeremy Castle makes $9,433 stock purchase By Investing.com - Investing.com South Africa
Oncology institute director Brad Hively acquires $9,433 in stock By Investing.com - Investing.com South Africa
Oncology institute director Mark Pacala acquires $94,338 in stock By Investing.com - Investing.com South Africa
Oncology institute director Mark Pacala acquires $94,338 in stock - Investing.com India
Oncology institute’s COO Jeremy Castle makes $9,433 stock purchase - Investing.com
Oncology Institute Executives Make Significant Stock Purchases - TradingView
Oncology institute director Karen Johnson acquires $37,734 in shares - Investing.com
Oncology institute CFO Robert Ross buys $9,433 in stock - Investing.com India
Oncology institute director Richard Barasch acquires $1.42 million in shares By Investing.com - Investing.com South Africa
Oncology institute director Richard Barasch acquires $1.42 million in shares - Investing.com India
Oncology institute CFO Robert Ross buys $9,433 in stock By Investing.com - Investing.com Canada
Oncology Institute, Inc. Earnings Call: Growth Amid Challenges - MSN
The Oncology Institute, Inc. (NASDAQ:TOI) Q4 2024 Earnings Call Transcript - Insider Monkey
Linnaeus Therapeutics Awarded Its Fourth Competitive SBIR Award by the National Cancer Institute Bringing Total SBIR Funding to $8.3 Million - Yahoo Finance
The Oncology Institute Inc (TOI) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst ... By GuruFocus - Investing.com Canada
The Oncology Institute Reports Strong Q4 Revenue Growth - TipRanks
Earnings call transcript: Oncology Institute Q4 2024 results show strategic growth - Investing.com Australia
Earnings call transcript: Oncology Institute Q4 2024 results show strategic growth By Investing.com - Investing.com South Africa
The Oncology Institute Announces $16.5 million Private Placement - GlobeNewswire
The Oncology Institute Secures $16.5 Million In Private Placement - Nasdaq
Oncology Institute, Inc. Prepares for PIPE Financing - TipRanks
The Oncology Institute, Inc. Announces $16.5 Million Private Placement Agreement - Nasdaq
Oncology Institute Achieves 17% Growth: Mixed Q4 Results Show Path to Profitability - StockTitan
The Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025 - GlobeNewswire
Oncology Institute Lands Major $16.5M Backing as Insiders Double Down - Stock Titan
Wilmot Cancer Institute earns prestigious National Cancer Institute designation - THE WELLSVILLE SUN
Ginsenoside Supplement Redsenol-1 Plus Included in National Cancer Institute's Drug Dictionary - 24-7 Press Release
The Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call - GlobeNewswire
TOIThe Oncology Institute Inc Latest Stock News & Market Updates - StockTitan
The Oncology Institute, Inc. Scheduled to Release Q4 and Full Year 2024 Financial Results on March 25, 2025 - Nasdaq
Market Cool On The Oncology Institute, Inc.'s (NASDAQ:TOI) Revenues Pushing Shares 28% Lower - Simply Wall St
When Will The Oncology Institute Report Q4 2024 Earnings? Key Date for TOI Investors - StockTitan
The Oncology Institute, Inc. (NASDAQ:TOI) Sees Significant Increase in Short Interest - MarketBeat
The Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Up 188.3% in February - Defense World
Oncology Institute Amends Facility Agreement with Deerfield - TipRanks
The Oncology Institute Announces Amendment to Facility Agreement and Debt Paydown - The Manila Times
TOI Slashes Debt While Expanding Patient Base: What's Behind This Strategic Financial Move? - StockTitan
NCCN Announces New Gastrointestinal Cancer Research Grants in Collaboration with Taiho Oncology, Inc. - BioSpace
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into The Oncology - ACCESS Newswire
Oncology Institute (NASDAQ:TOI) Trading Down 6.9%Here's What Happened - MarketBeat
Oncology Institute (NASDAQ:TOI) Stock Price Down 6.9% – Time to Sell? - Armenian Reporter
Oncology Institute Inc Stock (TOI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.15%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):